CONGENITAL HYPERINSULINISM INTERNATIONAL (EIN 203068945) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2006

Legal Domicile

Phone

9735660334

Tax Period

2024-01-01 to 2024-12-31

CONGENITAL HYPERINSULINISM INTERNATIONAL, founded in 2006, is a community nonprofit in the Diseases & Disorders sector that reported $1.3M in total revenue in fiscal year 2024. Revenue grew 11% year-over-year, indicating healthy expansion. Expenses of $1.1M left a modest 12% surplus.

Mission

Congenital Hyperinsulinism International's mission is to improve the lives of people living with congenital hyperinsulinism (or its consequences),a disorder that causes severe hypoglycemia that can lead to seizures,brain damage,or death, if untreated.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $260,171

Program Service Revenue $978,110

Investment Income $63,858

Other Revenue $-26,365

TOTAL REVENUE $1,275,774

Expense Breakdown

Grants Paid $109,097

Salaries & Benefits $581,741

Fundraising Expenses $74,746

Program Expenses $992,267

Other Expenses $436,017

TOTAL EXPENSES $1,126,855

Year-over-Year Comparison

	2024	2023	Change
Revenue	$1,275,774	$1,150,291	+0.1%
Expenses	$1,126,855	$1,043,446	+0.1%
Net Income	$148,919	$106,845	+0.4%

Key Indicators

✓ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✓ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

130

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$299,071

Total Directors

$299,071

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
JULIE RASKIN	CEO	40.00	Officer Director	$114,071	$0	$114,071
TAI PASQUINI	CRO	40.00	Officer Director	$95,000	$0	$95,000
JENNIFER SCHMITT	COO	40.00	Officer Director	$90,000	$0	$90,000
SHEILA BOSE	Secretary	6.00	Officer Director	$0	$0	$0
LAURA SULLIVAN	President	6.00	Officer Director	$0	$0	$0
JULIE SHELDON	Vice President	1.00	Officer Director	$0	$0	$0
MASON SMITH	Treasurer	2.00	Officer Director	$0	$0	$0
JUSTYNA MONTEMURRO	Director	1.00	Director	$0	$0	$0
PAM WILLIAMS	Director	1.00	Director	$0	$0	$0
TRUDY WARD	Director	1.00	Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	$1,275,774	$1,126,855	$2,173,955	$148,919
2023	$1,150,291	$1,043,446	$1,803,323	$106,845
2022	$1,262,625	$834,055	$1,644,315	$428,570
2021	$888,439	$541,828	$1,177,701	$346,611
2020	$707,807	$467,697	$1,097,548	$240,110
2019	$466,689	$494,501	$593,116	$-27,812
2018	$355,579	$382,051	$618,444	$-26,472

CONGENITAL HYPERINSULINISM INTERNATIONAL